JP2000509404A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2000509404A5 JP2000509404A5 JP1997539526A JP53952697A JP2000509404A5 JP 2000509404 A5 JP2000509404 A5 JP 2000509404A5 JP 1997539526 A JP1997539526 A JP 1997539526A JP 53952697 A JP53952697 A JP 53952697A JP 2000509404 A5 JP2000509404 A5 JP 2000509404A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96107282 | 1996-05-08 | ||
| EP96107282.4 | 1996-05-08 | ||
| PCT/EP1997/002268 WO1997041834A1 (en) | 1996-05-08 | 1997-05-04 | Cationic virosomes as transfer system for genetic material |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2000509404A JP2000509404A (ja) | 2000-07-25 |
| JP2000509404A5 true JP2000509404A5 (enExample) | 2005-02-10 |
Family
ID=8222763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP9539526A Pending JP2000509404A (ja) | 1996-05-08 | 1997-05-04 | 遺伝物質の導入システムとしてのカチオン性ヴィロソーム |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6210708B1 (enExample) |
| EP (1) | EP0902682A2 (enExample) |
| JP (1) | JP2000509404A (enExample) |
| KR (1) | KR100536983B1 (enExample) |
| CN (1) | CN1271992C (enExample) |
| AR (1) | AR007054A1 (enExample) |
| AU (1) | AU710170B2 (enExample) |
| BG (1) | BG102880A (enExample) |
| BR (1) | BR9709224A (enExample) |
| CA (1) | CA2253561A1 (enExample) |
| CO (1) | CO4600638A1 (enExample) |
| CZ (1) | CZ299809B6 (enExample) |
| EA (1) | EA003130B1 (enExample) |
| GT (1) | GT199700058A (enExample) |
| HR (1) | HRP970234B1 (enExample) |
| HU (1) | HUP9901790A3 (enExample) |
| ID (1) | ID17934A (enExample) |
| NO (1) | NO327726B1 (enExample) |
| NZ (1) | NZ332666A (enExample) |
| OA (1) | OA10916A (enExample) |
| PA (1) | PA8429201A1 (enExample) |
| PE (1) | PE65198A1 (enExample) |
| PL (1) | PL199201B1 (enExample) |
| SK (1) | SK152698A3 (enExample) |
| SV (1) | SV1997000032A (enExample) |
| TN (1) | TNSN97080A1 (enExample) |
| WO (1) | WO1997041834A1 (enExample) |
| ZA (1) | ZA973885B (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030113347A1 (en) * | 1991-05-08 | 2003-06-19 | Schweiz. Serum- & Impfinstitut Bern | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| AU9224398A (en) * | 1997-09-08 | 1999-03-29 | Promega Corporation | Method of (in vivo) transformation utilizing lipid vehicles |
| SE513149C2 (sv) * | 1997-12-05 | 2000-07-17 | Katarina Edwards | Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna |
| GB9813100D0 (en) * | 1998-06-18 | 1998-08-19 | Secr Defence | Method of forming liposomes |
| CA2388053A1 (en) * | 1999-10-08 | 2001-04-19 | Nika Health Products Limited | Cationic dosper virosomes |
| US6722282B2 (en) * | 1999-12-17 | 2004-04-20 | Schott Glas | Ignition capsule, which can be inductively activated, for occupant restraint systems, and a test circuit for said ignition capsule |
| EP1252897A4 (en) * | 2000-01-21 | 2003-07-30 | Hisamitsu Pharmaceutical Co | MEDICINES FOR GENE THERAPY |
| AU2002346084B2 (en) * | 2001-07-23 | 2006-11-16 | Onyx Pharmaceuticals, Inc. | Viral mutants that selectively replicate in targeted human cancer cells |
| KR100411234B1 (ko) * | 2001-08-14 | 2003-12-18 | 한국과학기술원 | 올리고뉴클레오티드 혼성화 미셀 및 그의 제조방법 |
| WO2003038103A1 (en) * | 2001-10-29 | 2003-05-08 | Atso Raasmaja | Method for gene transfection using synergistic combinations of cationic lipids and cationic polymers |
| US20040028687A1 (en) * | 2002-01-15 | 2004-02-12 | Waelti Ernst Rudolf | Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues |
| US20040176283A1 (en) * | 2002-04-01 | 2004-09-09 | Robinson John A. | Methods and compositions for the design of synthetic vaccines |
| EA008497B1 (ru) * | 2002-11-21 | 2007-06-29 | Певион Биотех Лтд. | Высокоэффективные способные к слиянию везикулы, способ их получения и фармацевтическая композиция, их содержащая |
| JP4838722B2 (ja) | 2003-10-24 | 2011-12-14 | ゲンシア コーポレーション | ポリヌクレオチドを送達する方法、及び送達用組成物 |
| US20090123468A1 (en) | 2003-10-24 | 2009-05-14 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8507277B2 (en) | 2003-10-24 | 2013-08-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides |
| US8133733B2 (en) | 2003-10-24 | 2012-03-13 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to target tissues |
| US20090208478A1 (en) * | 2003-10-24 | 2009-08-20 | Gencia Corporation | Transducible polypeptides for modifying metabolism |
| US8062891B2 (en) | 2003-10-24 | 2011-11-22 | Gencia Corporation | Nonviral vectors for delivering polynucleotides to plants |
| DE102004057303A1 (de) * | 2004-11-26 | 2006-06-01 | Merck Patent Gmbh | Stabile Kristallmodifikationen von DOTAP Chlorid |
| US20070172520A1 (en) * | 2005-11-18 | 2007-07-26 | University Of South Florida | Immunotargeting of Nonionic Surfactant Vesicles |
| CA2921063C (en) | 2006-09-15 | 2020-01-28 | Ottawa Hospital Research Institute | Oncolytic rhabdovirus |
| KR101242113B1 (ko) * | 2010-10-22 | 2013-03-19 | 고마바이오텍(주) | 유전자 전달용 양이온성 센다이 ｆ／ｈｎ 바이로좀 복합체 |
| WO2013032643A2 (en) * | 2011-08-31 | 2013-03-07 | Dicerna Pharmaceuticals, Inc. | Lipids capable of conformational change and their use in formulations to deliver therapeutic agents to cells |
| WO2013050048A2 (en) * | 2011-10-07 | 2013-04-11 | Skau Aps | Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped rna viruses |
| MX383392B (es) | 2016-09-27 | 2025-03-13 | Camurus Ab | Mezclas y formulaciones que comprenden una sal de alquil amonio de ácido etilendiaminotetraacético (edta). |
| CN109055432B (zh) * | 2018-08-16 | 2020-10-13 | 南京科佰生物科技有限公司 | 慢病毒感染试剂及其制备方法与应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US5264618A (en) * | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| PL296382A1 (en) * | 1991-02-02 | 1993-11-02 | Nika Health Products Ltd Li Li | Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system |
| CA2086831C (en) * | 1991-05-08 | 1999-03-16 | Reinhard Gluck | Immunostimulating and immunopotentiating reconstituted influenza virosomes and vaccines containing them |
| WO1993014744A1 (en) | 1992-02-04 | 1993-08-05 | Chiron Corporation | Non-toxic lipid vaccine formulations |
| US5631237A (en) | 1992-12-22 | 1997-05-20 | Dzau; Victor J. | Method for producing in vivo delivery of therapeutic agents via liposomes |
| US5578475A (en) * | 1993-07-12 | 1996-11-26 | Life Technologies, Inc. | Composition and methods for transfecting eukaryotic cells |
| JPH10505320A (ja) * | 1994-05-31 | 1998-05-26 | イネックス ファーマシューティカルズ コーポレイション | 治療剤のビロゾーム媒介細胞内輸送 |
| FR2726764B1 (fr) | 1994-11-14 | 1997-01-31 | Pasteur Merieux Serums Vacc | Adjuvant pour composition vaccinale |
-
1997
- 1997-05-04 AU AU27766/97A patent/AU710170B2/en not_active Ceased
- 1997-05-04 EP EP97921852A patent/EP0902682A2/en not_active Withdrawn
- 1997-05-04 JP JP9539526A patent/JP2000509404A/ja active Pending
- 1997-05-04 EA EA199800992A patent/EA003130B1/ru not_active IP Right Cessation
- 1997-05-04 CZ CZ0361498A patent/CZ299809B6/cs not_active IP Right Cessation
- 1997-05-04 KR KR1019980708906A patent/KR100536983B1/ko not_active Expired - Fee Related
- 1997-05-04 PL PL329853A patent/PL199201B1/pl not_active IP Right Cessation
- 1997-05-04 SK SK1526-98A patent/SK152698A3/sk unknown
- 1997-05-04 CA CA002253561A patent/CA2253561A1/en not_active Abandoned
- 1997-05-04 BR BR9709224A patent/BR9709224A/pt unknown
- 1997-05-04 HU HU9901790A patent/HUP9901790A3/hu unknown
- 1997-05-04 CN CNB971962324A patent/CN1271992C/zh not_active Expired - Fee Related
- 1997-05-04 NZ NZ332666A patent/NZ332666A/xx unknown
- 1997-05-04 WO PCT/EP1997/002268 patent/WO1997041834A1/en not_active Ceased
- 1997-05-06 ZA ZA973885A patent/ZA973885B/xx unknown
- 1997-05-07 SV SV1997000032A patent/SV1997000032A/es unknown
- 1997-05-07 PE PE1997000354A patent/PE65198A1/es not_active Application Discontinuation
- 1997-05-07 GT GT199700058A patent/GT199700058A/es unknown
- 1997-05-07 HR HR970234A patent/HRP970234B1/xx not_active IP Right Cessation
- 1997-05-07 CO CO97024481A patent/CO4600638A1/es unknown
- 1997-05-07 TN TNTNSN97080A patent/TNSN97080A1/fr unknown
- 1997-05-08 AR ARP970101917A patent/AR007054A1/es not_active Application Discontinuation
- 1997-05-08 PA PA19978429201A patent/PA8429201A1/es unknown
- 1997-05-09 ID IDP971533A patent/ID17934A/id unknown
-
1998
- 1998-10-29 BG BG102880A patent/BG102880A/xx unknown
- 1998-11-04 NO NO19985137A patent/NO327726B1/no not_active IP Right Cessation
- 1998-11-06 OA OA9800214A patent/OA10916A/en unknown
-
1999
- 1999-10-08 US US09/414,872 patent/US6210708B1/en not_active Expired - Fee Related